Stocks · Health care · Pharmaceutical Preparations

CORCEPT THERAPEUTICS INC

CORT Clue Score67
United States Fiscal year ends December CIK 0001088856 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Gary Charles Robb
17 Sep 2026
Chief Business Officer
Exercised, kept
17,493
$8.27
$144.67K
David L Mahoney
13 Mar 2026
Director
Exercised, kept
30,000
$5.86
$175.80K
James N Wilson
24 Feb 2026
Director
Exercised, kept
100,000
$3.88
$388.00K
Hazel Hunt
9 Feb 2026
Chief Scientific Officer
Exercised, kept
150,000
$3.88
$582.00K
G Leonard Baker Jr
27 Jan 2026
Director
Exercised, kept indirect
30,000
$15.15
$454.50K
G Leonard Baker Jr
27 Jan 2026
Director
Exercised, kept indirect
25,000
$10.50
$262.50K
G Leonard Baker Jr
27 Jan 2026
Director
Exercised, kept indirect
25,000
$14.08
$352.00K
G Leonard Baker Jr
27 Jan 2026
Director
Exercised, kept indirect
30,000
$12.13
$363.90K
G Leonard Baker Jr
27 Jan 2026
Director
Exercised, kept indirect
30,000
$5.86
$175.80K
Joseph K Belanoff
24 Dec 2025
Chief Executive Officer
Exercised, kept
550,000
$3.88
$2.13M
Gary Charles Robb
24 Dec 2025
Chief Business Officer
Exercised, kept
145,000
$3.88
$562.60K

What was left out

Form 4 filings counted 99
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 24
Sales straight out of an exercise 77
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 5,647,551
History held since 3 Oct 2006